+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Preventive Medicines Market Research Report by Distribution Channels (Diagnostic Centers and Hospitals), Specialty Areas, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 236 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5637024
UP TO OFF until Mar 31st 2023
The Global Preventive Medicines Market size was estimated at USD 347.97 billion in 2022, USD 376.49 billion in 2023, and is projected to grow at a CAGR of 8.67% to reach USD 676.98 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Preventive Medicines Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Preventive Medicines Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Preventive Medicines Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Preventive Medicines Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Preventive Medicines Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distribution Channels, the market is studied across Diagnostic Centers and Hospitals.
  • Based on Specialty Areas, the market is studied across Aerospace Medicine, General Preventive Medicine, Occupational Medicine, and Public Health.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preventive Medicines Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Preventive Medicines Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Preventive Medicines Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Preventive Medicines Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Preventive Medicines Market, including Aetna Inc., Affymetrix, Inc, Cancer Prevention Pharmaceuticals, Inc, Dilon Technologies, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC, Merck & Co. Inc., Myriad Genetics, Inc., Myriad Women’s Health, Inc., Novo Nordisk A\S, Omada Health, Inc., Omnicell, Inc., and Pfizer, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Preventive Medicines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Preventive Medicines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Preventive Medicines Market?
4. What is the competitive strategic window for opportunities in the Global Preventive Medicines Market?
5. What are the technology trends and regulatory frameworks in the Global Preventive Medicines Market?
6. What is the market share of the leading vendors in the Global Preventive Medicines Market?
7. What modes and strategic moves are considered suitable for entering the Global Preventive Medicines Market?
Frequently Asked Questions about the Global Preventive Medicines Market

What is the estimated value of the Global Preventive Medicines Market?

The Global Preventive Medicines Market was estimated to be valued at $347.97 Billion in 2022.

What is the growth rate of the Global Preventive Medicines Market?

The growth rate of the Global Preventive Medicines Market is 8.6%, with an estimated value of $676.98 Billion by 2030.

What is the forecasted size of the Global Preventive Medicines Market?

The Global Preventive Medicines Market is estimated to be worth $676.98 Billion by 2030.

Who are the key companies in the Global Preventive Medicines Market?

Key companies in the Global Preventive Medicines Market include Aetna Inc., Affymetrix, Inc, Cancer Prevention Pharmaceuticals, Inc, Dilon Technologies, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, McKesson Corporation, Medtronic PLC and Myriad Genetics, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prices of medicines, medical devices, medical treatments, and surgical procedures
5.1.1.2. Increasing interest of pharma companies in manufacturing of preventive medicine
5.1.1.3. Initiatives and events to spread education about the preventive medicines
5.1.2. Restraints
5.1.2.1. Loosely defined regional confirmations referring to preventive drug
5.1.3. Opportunities
5.1.3.1. Collaborative market ecosystem
5.1.3.2. Technology advancement to support prescription of tailor made solutions
5.1.4. Challenges
5.1.4.1. Absence of proven evidences or studies citing preventive medicine
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Preventive Medicines Market, by Distribution Channels
6.1. Introduction
6.2. Diagnostic Centers
6.3. Hospitals

7. Preventive Medicines Market, by Specialty Areas
7.1. Introduction
7.2. Aerospace Medicine
7.3. General Preventive Medicine
7.4. Occupational Medicine
7.5. Public Health

8. Americas Preventive Medicines Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Preventive Medicines Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Preventive Medicines Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Aetna Inc.
12.2. Affymetrix, Inc
12.3. Cancer Prevention Pharmaceuticals, Inc
12.4. Dilon Technologies, Inc.
12.5. Eli Lilly and Company
12.6. GlaxoSmithKline PLC
12.7. McKesson Corporation
12.8. Medtronic PLC
12.9. Merck & Co. Inc.
12.10. Myriad Genetics, Inc.
12.11. Myriad Women’s Health, Inc.
12.12. Novo Nordisk A\S
12.13. Omada Health, Inc.
12.14. Omnicell, Inc.
12.15. Pfizer, Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PREVENTIVE MEDICINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL PREVENTIVE MEDICINES MARKET DYNAMICS
FIGURE 11. GLOBAL PREVENTIVE MEDICINES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2030 (%)
FIGURE 13. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNELS, 2030
FIGURE 15. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2022 VS 2030 (%)
FIGURE 18. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 19. GLOBAL PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY SPECIALTY AREAS, 2030
FIGURE 20. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY AEROSPACE MEDICINE, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY GENERAL PREVENTIVE MEDICINE, 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY OCCUPATIONAL MEDICINE, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY PUBLIC HEALTH, 2018-2030 (USD BILLION)
FIGURE 24. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 25. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 26. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 27. AMERICAS PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 28. ARGENTINA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 29. BRAZIL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 30. CANADA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 31. MEXICO PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 32. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 33. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 35. UNITED STATES PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 36. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 37. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 38. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 39. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 40. AUSTRALIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 41. CHINA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. INDIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 43. INDONESIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 44. JAPAN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 45. MALAYSIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 46. PHILIPPINES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 47. SINGAPORE PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. SOUTH KOREA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. TAIWAN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. THAILAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. VIETNAM PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 56. DENMARK PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 57. EGYPT PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. FINLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 59. FRANCE PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 60. GERMANY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 61. ISRAEL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. ITALY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. NETHERLANDS PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. NIGERIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. NORWAY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. POLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. QATAR PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. RUSSIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. SAUDI ARABIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. SOUTH AFRICA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. SPAIN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. SWEDEN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. SWITZERLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. TURKEY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. UNITED ARAB EMIRATES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. UNITED KINGDOM PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. GLOBAL PREVENTIVE MEDICINES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 78. GLOBAL PREVENTIVE MEDICINES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 79. GLOBAL PREVENTIVE MEDICINES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL PREVENTIVE MEDICINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY AEROSPACE MEDICINE, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY AEROSPACE MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY AEROSPACE MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY GENERAL PREVENTIVE MEDICINE, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY GENERAL PREVENTIVE MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY GENERAL PREVENTIVE MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY OCCUPATIONAL MEDICINE, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY OCCUPATIONAL MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY OCCUPATIONAL MEDICINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY PUBLIC HEALTH, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY PUBLIC HEALTH, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL PREVENTIVE MEDICINES MARKET SIZE, BY PUBLIC HEALTH, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 27. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 28. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 29. AMERICAS PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 30. ARGENTINA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 31. ARGENTINA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 32. ARGENTINA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 33. BRAZIL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 34. BRAZIL PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 35. BRAZIL PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 36. CANADA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 37. CANADA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 38. CANADA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 39. MEXICO PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 40. MEXICO PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 41. MEXICO PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 42. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 43. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 44. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 45. UNITED STATES PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 46. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 47. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 48. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 49. ASIA-PACIFIC PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 50. AUSTRALIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 51. AUSTRALIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 52. AUSTRALIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 53. CHINA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 54. CHINA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 55. CHINA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 56. INDIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 57. INDIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 58. INDIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 59. INDONESIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 60. INDONESIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 61. INDONESIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 62. JAPAN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 63. JAPAN PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 64. JAPAN PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 65. MALAYSIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 66. MALAYSIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 67. MALAYSIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 68. PHILIPPINES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. PHILIPPINES PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 70. PHILIPPINES PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 71. SINGAPORE PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 72. SINGAPORE PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 73. SINGAPORE PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 74. SOUTH KOREA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 75. SOUTH KOREA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 76. SOUTH KOREA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 77. TAIWAN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. TAIWAN PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 79. TAIWAN PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 80. THAILAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 81. THAILAND PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 82. THAILAND PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 83. VIETNAM PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. VIETNAM PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 85. VIETNAM PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 90. DENMARK PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 91. DENMARK PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 92. DENMARK PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 93. EGYPT PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 94. EGYPT PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 95. EGYPT PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 96. FINLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 97. FINLAND PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 98. FINLAND PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 99. FRANCE PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 100. FRANCE PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 101. FRANCE PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 102. GERMANY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 103. GERMANY PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 104. GERMANY PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 105. ISRAEL PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. ISRAEL PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 107. ISRAEL PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 108. ITALY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 109. ITALY PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 110. ITALY PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 111. NETHERLANDS PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 112. NETHERLANDS PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 113. NETHERLANDS PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 114. NIGERIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 115. NIGERIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 116. NIGERIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 117. NORWAY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. NORWAY PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 119. NORWAY PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 120. POLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 121. POLAND PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 122. POLAND PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 123. QATAR PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. QATAR PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 125. QATAR PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 126. RUSSIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. RUSSIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 128. RUSSIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 129. SAUDI ARABIA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. SAUDI ARABIA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 131. SAUDI ARABIA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 132. SOUTH AFRICA PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. SOUTH AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 134. SOUTH AFRICA PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 135. SPAIN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. SPAIN PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 137. SPAIN PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 138. SWEDEN PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. SWEDEN PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 140. SWEDEN PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 141. SWITZERLAND PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. SWITZERLAND PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 143. SWITZERLAND PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 144. TURKEY PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. TURKEY PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 146. TURKEY PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 147. UNITED ARAB EMIRATES PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. UNITED ARAB EMIRATES PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 149. UNITED ARAB EMIRATES PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 150. UNITED KINGDOM PREVENTIVE MEDICINES MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. UNITED KINGDOM PREVENTIVE MEDICINES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD BILLION)
TABLE 152. UNITED KINGDOM PREVENTIVE MEDICINES MARKET SIZE, BY SPECIALTY AREAS, 2018-2030 (USD BILLION)
TABLE 153. GLOBAL PREVENTIVE MEDICINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 154. GLOBAL PREVENTIVE MEDICINES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 155. GLOBAL PREVENTIVE MEDICINES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 156. GLOBAL PREVENTIVE MEDICINES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 157. GLOBAL PREVENTIVE MEDICINES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 158. GLOBAL PREVENTIVE MEDICINES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 159. GLOBAL PREVENTIVE MEDICINES MARKET MERGER & ACQUISITION
TABLE 160. GLOBAL PREVENTIVE MEDICINES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 161. GLOBAL PREVENTIVE MEDICINES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 162. GLOBAL PREVENTIVE MEDICINES MARKET INVESTMENT & FUNDING
TABLE 163. GLOBAL PREVENTIVE MEDICINES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 164. GLOBAL PREVENTIVE MEDICINES MARKET: LICENSE & PRICING

Companies Mentioned

  • Aetna Inc.
  • Affymetrix, Inc
  • Cancer Prevention Pharmaceuticals, Inc
  • Dilon Technologies, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • McKesson Corporation
  • Medtronic PLC
  • Merck & Co. Inc.
  • Myriad Genetics, Inc.
  • Myriad Women’s Health, Inc.
  • Novo Nordisk A\S
  • Omada Health, Inc.
  • Omnicell, Inc.
  • Pfizer, Inc.

Methodology

Loading
LOADING...